Warma Neil K
Insider CIK 1437911 · OPXA President, CEO and Acting CFO, Director · PMN Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PMN ProMIS Neurosciences Inc. | A Award deriv | 2026-05-20 | 2026-05-22 | 160,000 | — | $0 | 160,000 | SEC↗ |
| PMN ProMIS Neurosciences Inc. | A Award deriv | 2026-02-03 | 2026-02-05 | 6,183 | — | $0 | 6,183 | SEC↗ |
| PMN ProMIS Neurosciences Inc. | A Award | 2026-02-03 | 2026-02-05 | 6,183 | $12.13 | $75.0K | 6,183 | SEC↗ |
| PMN ProMIS Neurosciences Inc. | A Award deriv | 2025-09-22 | 2025-09-24 | 600,000 | — | $0 | 600,000 | SEC↗ |
| PMN ProMIS Neurosciences Inc. | A Award deriv | 2024-10-08 | 2024-10-10 | 1,144,122 | — | $0 | 1,352,455 | SEC↗ |
| PMN ProMIS Neurosciences Inc. | A Award deriv | 2024-10-08 | 2024-10-10 | 490,338 | — | $0 | 1,842,739 | SEC↗ |
| PMN ProMIS Neurosciences Inc. | A Award deriv | 2024-01-02 | 2024-01-05 | 200,000 | — | $0 | 208,333 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2016-05-16 | 2016-05-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise deriv | 2015-04-08 | 2015-04-09 | 37,247 | — | $0 | 0 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise deriv | 2015-04-08 | 2015-04-09 | 37,247 | — | $0 | 37,247 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise | 2015-04-08 | 2015-04-09 | 37,247 | — | $0 | 144,881 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2015-03-02 | 2015-03-04 | 120,000 | — | $0 | 120,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | P Buy | 2014-09-16 | 2014-09-17 | 10,000 | $1.11 | $11.1K | 107,634 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2014-02-28 | 2014-03-04 | 316,250 | — | $0 | 316,250 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2014-02-28 | 2014-03-04 | 51,748 | — | $0 | 97,634 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-11-08 | 2013-11-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2013-11-08 | 2013-11-12 | 28,571 | — | $0 | 45,886 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | C Conversion deriv | 2013-09-24 | 2013-09-26 | 0 | — | $0 | 0 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | C Conversion | 2013-09-24 | 2013-09-26 | 8,076 | $1.91 | $15.4K | 17,315 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2013-06-30 | 2013-07-02 | 581 | $1.54 | $895 | 9,239 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-04-29 | 2013-05-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2013-04-29 | 2013-05-01 | 28,571 | — | $0 | 37,229 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-02-04 | 2013-05-01 | 95,970 | — | $0 | 95,970 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-02-04 | 2013-06-14 | 95,970 | — | $0 | 95,970 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-01-29 | 2013-01-31 | 688 | — | $0 | 688 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2012-12-31 | 2013-01-28 | 600 | $1.33 | $798 | 8,658 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-09-12 | 2013-01-28 | 43,623 | — | $0 | 43,623 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-07-25 | 2012-07-27 | 14,063 | — | $0 | 150 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-07-25 | 2012-07-27 | 0 | — | $0 | 14,063 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-01-06 | 2012-01-10 | 174,493 | — | $0 | 174,493 | SEC↗ |